Jeffrey T. Chapman

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

Francis X. McCormack, Yoshikazu Inoue, Joel Moss et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.

Robert M. Bernstein, Stephen H. Morgan, Jeffrey T. Chapman et al. · BMJ · 1984 · 549 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

The NHLBI Lymphangioleiomyomatosis Registry

Jay H. Ryu, Joel Moss, Gerald J. Beck et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 479 citations

Medicine, Pathology, Cellular Pathology +10

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management

Francis X. McCormack, Nishant Gupta, Geraldine R. Finlay et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 368 citations

Medicine, Internal Medicine, Pulmonology +3

Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation

Scott M. Palmer, Ajit P. Limaye, Missy Banks et al. · Annals of Internal Medicine · 2010 · 252 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17